By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


SEARCH JOBS


Industry
Big Pharma


Collaborations

CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Incyte Corporation 

Maxygen, Inc. 

Intergen Company 





Company News
Novo Nordisk A/S (NVO) And Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement For Verizon Indycar Series 12/12/2014 8:08:36 AM
Novo Nordisk A/S (NVO) Release: Novoeight Phase 3 Data Show Reduction In Annualised Bleeding Rate Over Time In People With Haemophilia A 12/8/2014 7:45:24 AM
Novo Nordisk A/S (NVO) To Present Hemophilia Portfolio And Pipeline Data At 56th American Society of Hematology Meeting 12/1/2014 4:01:03 PM
Novo Nordisk A/S (NVO) Restructures Executive Board As Chief Of Staff Leaves 11/26/2014 6:27:04 AM
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014 11:13:28 AM
Novo Nordisk A/S (NVO) Re-Launches Cornerstones4Care® With Customized Diabetes Patient Support Program 11/5/2014 8:59:43 AM
Novo Nordisk A/S (NVO) Release: New Phase 3a Data Demonstrate That 9 Out Of 10 Adults With Obesity Lost Weight With Liraglutide 3 Mg And Clinical Trial Completers Lost An Average Of 9.2% 11/4/2014 6:38:58 AM
Nine Out Of 10 Lost Weight With Novo Nordisk A/S (NVO)'s Obesity Drug Liraglutide 11/4/2014 6:38:08 AM
Novo Nordisk A/S (NVO) Commits $130 Million In Diabetes Research In Denmark 10/31/2014 6:46:30 AM
Novo Nordisk A/S (NVO) More Mindful On Timing Of U.S. Tresiba Launch 10/30/2014 6:46:47 AM
12345678910...
//-->